Apollo Hospitals Enterprise has reported a profit after tax (PAT) of Rs3.05bn ($36.32m) in the first quarter (Q1) of fiscal year 2025 (FY25), a year-over-year (YoY) growth of 83% from Rs1.66bn ($19.77m) in Q1 FY24.
For the quarter ending on 30 June 2024, the Indian hospitals operator reported diluted earnings per share (EPS) at Rs21.23.
The company's revenues saw a 15% YoY increase, reaching Rs50.86bn in Q1 FY25 from Rs44.17bn in Q1 FY24.
The consolidated earnings before interest, taxes, depreciation, and amortisation (EBITDA) also reflected positive growth, with a 33% YoY rise to Rs6.75bn in Q1 FY25, after accounting for Apollo 24/7 costs of Rs1.49bn, from Rs5.09bn in Q1 last fiscal year.
The Healthcare Services (HCS) business segment of Apollo Hospitals reported a PAT of Rs3.28bn in Q1 FY25, a 24% YoY growth from Rs2.63bn in the same quarter of previous fiscal year.
HCS revenue for the reported quarter was Rs26.37bn, a 15% increase from Rs22.93bn in Q1 FY24.
As of 30 June 2024, the hospital network operated 7,942 beds, excluding AHLL & managed beds, with overall occupancy rising to 68% from 62% in the same period last year.
This was supported by an 11% increase in inpatient (IP) volume as well as a 13% rise in new outpatient (OP) registrations.
Apollo Health and Lifestyle Limited (AHLL), another segment of the company, reported a revenue of Rs3.66bn, marking a 15% YoY increase from Rs3.18bn in Q1 FY24.
AHLL's PAT loss improved to Rs1.02bn from a loss of Rs1.47bn in the previous year's Q1.
The diagnostics business of Apollo Hospitals has an extensive network of more than 2,300 centres across 300 cities, serving more than 15,000 customers daily.
Furthermore, Apollo HealthCo, the company's digital healthcare and omni-channel pharmacy platform, reported a 15% YoY revenue growth to Rs20.82bn.
The PAT loss for Apollo HealthCo narrowed to Rs1.29bn from Rs8.26bn in Q1 FY24.
Apollo Hospitals Group chairman Dr Prathap Reddy said: “In the first quarter of FY25, we have seen significant growth and improved the reach of our retail operations.
“As we continue our growth journey, we remain dedicated to advancing healthcare excellence, implementing innovative solutions, and improving access to the best healthcare services throughout India and beyond.”
